Literature DB >> 21752901

Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Jameela Khan1, Clare E Davy, Pauline B McIntosh, Deborah J Jackson, Steven Hinz, Qian Wang, John Doorbar.   

Abstract

The human papillomavirus (HPV) type 16 E1^E4 (16E1^E4) protein is expressed in the middle to upper layers of infected epithelium and has several roles within the virus life cycle. It is apparent that within the epithelium there are multiple species of 16E1^E4 that differ in length and/or degree of phosphorylation and that some or all of these can associate with the cellular keratin networks, leading to network disruption. We show here that the cellular cysteine protease calpain cleaves the 16E1^E4 protein after amino acid 17 to generate species that lack the N terminus. These C-terminal fragments are able to multimerize and form amyloid-like fibers. This can lead to accumulation of 16E1^E4 and disruption of the normal dynamics of the keratin networks. The cleavage of E1^E4 proteins by calpain may be a common strategy used by α-group viruses, since we show that cleavage of type 18 E1^E4 in raft culture is also dependent on calpain. Interestingly, the cleavage of 16E1^E4 by calpain appears to be highly regulated as differentiation of HPV genome-containing cells by methylcellulose is insufficient to induce cleavage. We hypothesize that this is important since it ensures that the formation of the amyloid fibers is not prematurely triggered in the lower layers and is restricted to the upper layers, where calpain is active and where disruption of the keratin networks may aid virus release.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752901      PMCID: PMC3196407          DOI: 10.1128/JVI.02158-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures.

Authors:  Paul F Lambert; Michelle A Ozbun; Asha Collins; Sigrid Holmgren; Denis Lee; Tomomi Nakahara
Journal:  Methods Mol Med       Date:  2005

3.  Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.

Authors:  Gillian L Knight; Andrew S Turnell; Sally Roberts
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1--E4 protein and provides a molecular basis for its accumulation.

Authors:  Pauline B McIntosh; Stephen R Martin; Deborah J Jackson; Jameela Khan; Erin R Isaacson; Lesley Calder; Kenneth Raj; Heather M Griffin; Qian Wang; Peter Laskey; John F Eccleston; John Doorbar
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein.

Authors:  Grant A Darnell; Wayne A Schroder; Toni M Antalis; Eleanore Lambley; Lee Major; Joy Gardner; Geoff Birrell; Angel Cid-Arregui; Andreas Suhrbier
Journal:  J Biol Chem       Date:  2007-10-31       Impact factor: 5.157

7.  The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.

Authors:  Ian Bell; Ashley Martin; Sally Roberts
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

8.  Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle.

Authors:  Tomomi Nakahara; Woei Ling Peh; John Doorbar; Denis Lee; Paul F Lambert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 9.  Molecular biology of human papillomavirus infection and cervical cancer.

Authors:  John Doorbar
Journal:  Clin Sci (Lond)       Date:  2006-05       Impact factor: 6.124

Review 10.  The calpains: modular designs and functional diversity.

Authors:  Dorothy E Croall; Klaus Ersfeld
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  11 in total

Review 1.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

2.  HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures.

Authors:  Eun-Young Kho; Hsu-Kun Wang; N Sanjib Banerjee; Thomas R Broker; Louise T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-09       Impact factor: 11.205

3.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

4.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Authors:  Heather Griffin; Yasmina Soneji; Romy Van Baars; Rupali Arora; David Jenkins; Miekel van de Sandt; Zhonglin Wu; Wim Quint; Robert Jach; Krzysztof Okon; Hubert Huras; Albert Singer; John Doorbar
Journal:  Mod Pathol       Date:  2015-05-08       Impact factor: 7.842

Review 6.  The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.

Authors:  Van G Wilson
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

Review 7.  Epithelial Intermediate Filaments: Guardians against Microbial Infection?

Authors:  Florian Geisler; Rudolf E Leube
Journal:  Cells       Date:  2016-06-27       Impact factor: 6.600

Review 8.  Potential Role of E4 Protein in Human Papillomavirus Screening: a Review

Authors:  Aidy Irman Yajid; Mohd Azali Zakariah; Anani Aila Mat Zin; Nor Hayati Othman
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

9.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14

10.  HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.

Authors:  Nagayasu Egawa; Qian Wang; Heather M Griffin; Isao Murakami; Deborah Jackson; Radma Mahmood; John Doorbar
Journal:  PLoS Pathog       Date:  2017-03-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.